; and (ii) at least once a month to the extent that the administration of such psychotropic drug to such resident is in accordance with the plan of care that the resident has in place. (D) Compliance Effective beginning on the date that is one year and 180 days after the date of the enactment of this paragraph, a nursing facility shall comply with the standardized protocol developed under subparagraph (A). (E) No preemption Nothing in this paragraph shall preempt any provision of State or Federal law that provides broader rights with respect to written informed consent for residents of facilities. . (3) GAO study and report on informed consent laws with respect to prescribing of psychotropic drugs (A) Study The Comptroller General of the United States (in this paragraph referred to as the Comptroller General ) shall conduct a study of State laws and regulations concerning informed consent with respect to the administration of a psychotropic drug with regard to the effectiveness of such laws and practices in changing the frequency of prescribing of psychotropic drugs to older adults. The study shall include an analysis as to whether in the case of States that have not enacted such informed consent laws, such States have developed other mechanisms to guide appropriate prescribing of psychotropic drugs in older adults with dementia. (B) Report Not later than 180 days after the date of enactment of this Act, the Comptroller General shall submit to the Secretary of Health and Human Services and to Congress a report containing the results of the study conducted under subparagraph (A), together with such recommendations as the Comptroller General determines appropriate. (b) Development of measure of utilization of psychotropic drugs for inclusion on Nursing Home Compare website (1) Medicare Section 1819(i) of the Social Security Act ( 42 U.S.C. 1395i–3(i) ) is amended— (A) by redesignating paragraph (3) as paragraph (4)